Global Information Lookup Global Information

Transient neonatal myasthenia gravis information


Transient neonatal myasthenia gravis
SpecialtyPediatrics, Pediatric neurology, Pediatric pulmonology, Pediatric intensive care medicine
Symptomsskeletal muscles weaknesses and, in rare cases. organ deformities in one or more areas of the body in fetuses and newborns
ComplicationsMyasthenic crisis, i.e., weakness in the lungs skeletal muscles causing potentially lethal respiratory failure
Usual onsetDuring fetal development
DurationMost cases remit by 4 months after birth
CausesAntibodies against proteins in the neuromuscular junction of skeletal muscles made by a mother with myasthenia gravis and passed from her blood to her fetus's blood
Diagnostic methodClassic symptoms of transient neonatal myasthenia gravies in the offspring of mothers who have myasthenia gravis
Differential diagnosisJuvenile myasthenia gravis, congenital myasthenia gravis
FrequencyRare

Transient neonatal myasthenia gravis, i.e., TNMG (also termed neonatal myasthenia gravis[1]), and its more severe form, fetal acetylcholine receptor inactivation syndrome (i.e., FARIS), is one of the various types of myasthenia gravis (i.e., MG).[2] MG is an autoimmune disease in which individuals form antibodies that circulate in their blood, enter tissues, bind to certain proteins in the neuromuscular junctions of skeletal muscles, and thereby reduce the number or ability of these skeletal muscles to contract when appropriately stimulated by acetylcholine. The affected skeletal muscles are easily fatigable, i.e., weakened after relatively little use. There are 3 types of antibodies that are known to cause TNMG/FARIS: antibodies binding to the adult form of the nicotinic acetylcholine receptor, i.e., adult nAChR, are responsible for most cases of TNMG while antibodies binding to two proteins near these nAChRs, i.e., the MuSK protein and low-density lipoprotein receptor-related protein 4 (i.e., LRP4) are responsible for many of the remaining cases of TNMG.[3][4][5] Antibodies directed at the fetal form of nAChRs are responsible for all cases of FARIS.[1][4][5]

MG may present as muscle weakness in different areas of the body: a) ocular MG is skeletal muscle weakness in the eyes that causes ptosis (i.e., eyelid drooping), weak eyelid closure, strabismus (i.e., one eye turned in a direction different from the other eye), diplopia (i.e., double vision), and/or complex ophthalmoplegias (e.g., weakness or paralysis of one or more extraocular muscles responsible for eye movements);[6][7][8] b) limb/axial MG is skeletal muscle weakness of the arms, legs, trunk, and/or head that causes weak finger extension, wrist drop, foot and hand dorsiflexions (backward bending or contraction of the foot or hand), difficulty in raising the arms above the head, getting up from low seats or toilets, walking long distances, and climbing stairs, and head drop (i.e., relaxing of the neck muscles);[9][10] and c) bulbar MG is weakness of the skeletal muscles activated by nerves from the lower part of the brain stem termed the medulla oblongata that causes slurred speech, dysphagia (i.e., difficulty in swallowing), dysphonia (i.e., hoarse voice), bilateral facial nerve weakness, jaw weakness, and weaknesses of the respiratory muscles that may lead to a myasthenic crisis, i.e., life-threatening respiratory arrest.[9][11] MG, particularly in long-standing cases, may have two or all three ocular, limb/axial, or bulbar symptoms.[9][10][11] MG has also been separated into only two types: ocular MG and generalized MG, i.e., all other types of MG.[12] MG is caused by antibodies directed at adult nAChR (70-85% of cases), the MUSK protein (1-10 % of cases), or the LRP4 protein (1% to 5% of cases).[13][14] Uncommonly, individuals present with the symptoms of MG but test negative for antibodies to the nAChR, MuSK, and LRP4 protein, i.e., they have triple seronegative MG. This may be due to laboratory test inaccuracies, decreased antibody production, immunosenescence, previous immunosuppressive therapies, acquired immunodeficiencies, depletion of the antigen attacked by the MG-causing antibody, or other diseases that mimic MG.[15] It is also possible that other proteins found to be elevated in some cases of MG (i.e., the agrin protein) or some as yet unidentified protein will be found to cause MG.[14]

TNMG is one form of pediatric myasthenia gravis. Pediatric myasthenia gravis has two other forms which should not be confused with TNMG. Juvenile myasthenia gravis (i.e., JMG) refers to cases of MG that occur in children before the age of 19. It has been diagnosed in children as young as 8 months of age but, unlike TNMG, has not been diagnosed in fetuses (i.e., 9 weeks or older unborn offspring) or newborns.[12] JMG accounts for about 10–15% of all MG cases and appears to be more prevalent in Asian than white populations, i.e., it represents up to 50% of all TNMG in Asians. Unlike TNMG but similar to MG, JMG is caused by the afflicted individuals production of antibodies directed at adult nAChRs, MuSK, or LRP4. (Individuals with JMG have an increased rate of also having Hashimoto disease, polymyositis, and other autoimmune diseases.[12][16]) The other form of pediatric myasthenia gravis is termed the congenital myasthenic syndrome, i.e., CMGS. CMGS is not an autoimmune disease. It is a group of rare hereditary disorders in which the neuromuscular transmission in their skeletal muscles is dysfunctional due to the inheritance of defective genes.[17] The defective genes code for proteins in the neuromuscular junctions that, due to their defects, reduce the number of nAChRs that are functional.[5] One study reviewed the mutations in 32 genes that were responsible for causing CMGS. These genes' protein products function as ion-channels, enzymes, or structural, signaling, sensor, or transporter proteins in the neuromuscular junctions. The skeletal muscles of individuals with one of these mutations exhibited easy fatigability, hypotonia (i.e., poor muscle tone), weakness, and/or delayed development of facial, bulbar, limb, respiratory, head, and/or back skeletal muscles.[18] Mutations in the COLQ, CHRNE, RAPSN, Dok-7, and CHAT genes were the most common mutations causing CMGS. None of the reported mutations caused pure ocular myasthenia, i.e., skeletal muscles weaknesses in the eye but not other areas.[18]

  1. ^ a b Gilhus NE (July 2023). "Myasthenia gravis, respiratory function, and respiratory tract disease". Journal of Neurology. 270 (7): 3329–3340. doi:10.1007/s00415-023-11733-y. PMC 10132430. PMID 37101094.
  2. ^ Lindroos JL, Bjørk MH, Gilhus NE (February 2024). "Transient Neonatal Myasthenia Gravis as a Common Complication of a Rare Disease: A Systematic Review". Journal of Clinical Medicine. 13 (4): 1136. doi:10.3390/jcm13041136. PMC 10889526. PMID 38398450.
  3. ^ Gilhus NE, Hong Y (December 2018). "Maternal myasthenia gravis represents a risk for the child through autoantibody transfer, immunosuppressive therapy and genetic influence". European Journal of Neurology. 25 (12): 1402–1409. doi:10.1111/ene.13788. PMID 30133097.
  4. ^ a b Nair SS, Jacob S (2023). "Novel Immunotherapies for Myasthenia Gravis". ImmunoTargets and Therapy. 12: 25–45. doi:10.2147/ITT.S377056. PMC 10082579. PMID 37038596.
  5. ^ a b c Chia R, Saez-Atienzar S, Murphy N, Chiò A, Blauwendraat C, Roda RH, Tienari PJ, Kaminski HJ, Ricciardi R, Guida M, De Rosa A, Petrucci L, Evoli A, Provenzano C, Drachman DB, Traynor BJ (February 2022). "Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study". Proceedings of the National Academy of Sciences of the United States of America. 119 (5). Bibcode:2022PNAS..11908672C. doi:10.1073/pnas.2108672119. PMC 8812681. PMID 35074870.
  6. ^ Ng JY, Zarook E, Nicholson L, Khanji MY, Chahal CA (October 2023). "Eyes and the heart: what a clinician should know". Heart (British Cardiac Society). 109 (22): 1670–1676. doi:10.1136/heartjnl-2022-322081. PMC 10646879. PMID 37507215.
  7. ^ O'Hare M, Doughty C (December 2019). "Update on Ocular Myasthenia Gravis". Seminars in Neurology. 39 (6): 749–760. doi:10.1055/s-0039-1700527. PMID 31847046.
  8. ^ Deymeer F (December 2020). "Myasthenia gravis: MuSK MG, late-onset MG and ocular MG". Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology. 39 (4): 345–352. doi:10.36185/2532-1900-038. PMC 7783433. PMID 33458590.
  9. ^ a b c Ciafaloni E (December 2019). "Myasthenia Gravis and Congenital Myasthenic Syndromes". Continuum (Minneapolis, Minn.). 25 (6): 1767–1784. doi:10.1212/CON.0000000000000800. PMID 31794470.
  10. ^ a b Dresser L, Wlodarski R, Rezania K, Soliven B (May 2021). "Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations". Journal of Clinical Medicine. 10 (11): 2235. doi:10.3390/jcm10112235. PMC 8196750. PMID 34064035.
  11. ^ a b Gosain D, Das T (September 2023). "Myasthenia Gravis Presenting as Bulbar Palsy". Cureus. 15 (9): e46082. doi:10.7759/cureus.46082. PMC 10611170. PMID 37900462.
  12. ^ a b c Maeda M, Shimomura H, Tokunaga S, Taniguchi N, Lee T, Takeshima Y (May 2024). "Clinical Characteristics and Treatment of Juvenile Myasthenia Gravis-A Single-Center Experience". Children (Basel, Switzerland). 11 (5): 572. doi:10.3390/children11050572. PMC 11120409. PMID 38790567.
  13. ^ Li W, Liu P, Cui W, Wang S, Ji Y, Zhang L, He X, Zhou S, Shen T, Zhao X, Lv J, Zhang Y, Zhang J, Fang H, Yang J, Zhang Y, Cui X, Zhang Q, Gao F (June 2023). "Clinical characteristics of anti-AChR-MuSK-LRP4 antibody-negative myasthenia gravis in China". Muscle & Nerve. 67 (6): 481–488. doi:10.1002/mus.27822. PMID 36945795.
  14. ^ a b Li Y, Peng Y, Yang H (April 2023). "Serological diagnosis of myasthenia gravis and its clinical significance". Annals of Translational Medicine. 11 (7): 290. doi:10.21037/atm-19-363. PMC 10116419. PMID 37090043.
  15. ^ Vinciguerra C, Bevilacqua L, Lupica A, Ginanneschi F, Piscosquito G, Rini N, Rossi A, Barone P, Brighina F, Di Stefano V (September 2023). "Diagnosis and Management of Seronegative Myasthenia Gravis: Lights and Shadows". Brain Sciences. 13 (9): 1286. doi:10.3390/brainsci13091286. PMC 10526522. PMID 37759888.
  16. ^ Peragallo JH (May 2017). "Pediatric Myasthenia Gravis". Seminars in Pediatric Neurology. 24 (2): 116–121. doi:10.1016/j.spen.2017.04.003. PMID 28941526.
  17. ^ Estephan EP, Zambon AA, Thompson R, Polavarapu K, Jomaa D, Töpf A, Helito PV, Heise CO, Moreno CA, Silva AM, Kouyoumdjian JA, Morita MD, Reed UC, Lochmüller H, Zanoteli E (March 2022). "Congenital myasthenic syndrome: Correlation between clinical features and molecular diagnosis". European Journal of Neurology. 29 (3): 833–842. doi:10.1111/ene.15173. PMID 34749429.
  18. ^ a b Finsterer J (February 2019). "Congenital myasthenic syndromes". Orphanet Journal of Rare Diseases. 14 (1): 57. doi:10.1186/s13023-019-1025-5. PMC 6390566. PMID 30808424.

and 20 Related for: Transient neonatal myasthenia gravis information

Request time (Page generated in 0.835 seconds.)

Myasthenia gravis

Last Update:

life, known as neonatal myasthenia or more specifically transient neonatal myasthenia gravis. Diagnosis can be supported by blood tests for specific antibodies...

Word Count : 6532

Transient neonatal myasthenia gravis

Last Update:

Transient neonatal myasthenia gravis, i.e., TNMG (also termed neonatal myasthenia gravis), and its more severe form, fetal acetylcholine receptor inactivation...

Word Count : 3710

Neuromuscular junction disease

Last Update:

of myasthenia gravis.(reference 5) Here is a list of the diseases: myasthenia gravis, neonatal myasthenia gravis, drug-induced myasthenia gravis and...

Word Count : 2483

Myasthenia

Last Update:

Myasthenia is a medical term for muscle weakness. The term may also refer to: Myasthenia gravis Ocular myasthenia Transient neonatal myasthenia gravis...

Word Count : 57

Neuromuscular junction

Last Update:

its receptor. It is not known if seronegative myasthenia gravis will respond to standard therapies. Neonatal MG is an autoimmune disorder that affects 1...

Word Count : 4062

Salbutamol

Last Update:

the symptoms of newborns and adolescents with myasthenia gravis and transient neonatal myasthenia gravis. The most common side effects are fine tremor...

Word Count : 3007

Mechanical ventilation

Last Update:

Guillain–Barré syndrome, myasthenia gravis including transient neonatal myasthenia gravis, etc. Newborn premature infants with neonatal respiratory distress...

Word Count : 5602

Tocolytic

Last Update:

birth represents one of the leading causes of neonatal morbidity and mortality, the goal is to prevent neonatal morbidity and mortality through delaying delivery...

Word Count : 2486

Oxazepam

Last Update:

and gradual dose reduction regimen. Oxazepam is contraindicated in myasthenia gravis, chronic obstructive pulmonary disease, and limited pulmonary reserve...

Word Count : 3075

Lupus

Last Update:

mononeuritis multiplex), movement disorder (more specifically, chorea), myasthenia gravis, myelopathy, cranial neuropathy and plexopathy.[citation needed] Neurological...

Word Count : 13043

Glycogen storage disease

Last Update:

neuromuscular junction can cause abnormal muscle fatigue, such as myasthenia gravis, an autoimmune disease. Similar, are Lambert–Eaton myasthenic syndrome...

Word Count : 6092

Propranolol

Last Update:

hypertension may be aggravated without prior alpha blocker therapy Myasthenia gravis, which may be worsened Other drugs with bradycardic effects Propranolol...

Word Count : 4803

Lorazepam

Last Update:

reduce the person's ability to protect his or her airway during sleep. Myasthenia gravis – This condition is characterized by muscle weakness, so a muscle...

Word Count : 8518

List of dog diseases

Last Update:

cause of regurgitation in dogs. Other causes of megaesophagus include myasthenia gravis, lead poisoning, and Addison's disease. Gastric dilatation volvulus...

Word Count : 14804

T helper cell

Last Update:

will cause type 2 antibody-dependent cytotoxic hypersensitivity. Myasthenia gravis or Graves' disease belong to this category. The interactions between...

Word Count : 6597

Pemphigus

Last Update:

more frequent among Ashkenazi Jews. Rarely, it is associated with myasthenia gravis. Nail disease may be the only finding and has prognostic value in...

Word Count : 1951

Methylprednisolone

Last Update:

or hypertension, peptic ulcer, renal insufficiency, osteoporosis, myasthenia gravis, glaucoma, and diabetes. Psychic manifestations may appear while taking...

Word Count : 5140

Side effects of penicillin

Last Update:

tremors, seizures, blindness, vocalization, agitation, cardiac arrest and transient loss of vision. Penicillin is known to become less effective as strains...

Word Count : 1843

Hypothyroidism

Last Update:

immune-mediated diseases such as diabetes mellitus type 1, pernicious anemia, myasthenia gravis, celiac disease, rheumatoid arthritis and systemic lupus erythematosus...

Word Count : 8155

Outline of immunology

Last Update:

Goodpasture's syndrome Type 5 / Receptor mediated Graves' disease Myasthenia gravis Type 3 hypersensitivity / Immune complex Foreign Henoch–Schönlein...

Word Count : 2656

PDF Search Engine © AllGlobal.net